Can you trust the labels on CBD products? According to a new study published in JAMA Open Network, the answer is maybe not. In a new study, Johns Hopkins Medicine researchers tested more than 100 topical cannabidiol (CBD) products from both retail stores and online. They found significant evidence ofRead
Ever wondered if it’s safe to drive when taking CBD? Australian researchers now have an answer to that question. According to a study in the Journal of Psychopharmacology, CBD has “no impact” on a person’s ability to drive — even at very high doses. Study Details For the study, 17Read
Recent research shows that CBD appears to reduce the “cytokine storm” that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face ofRead
Just as FDA is a new months away from making a ruling on the new drug aducanaumab that is reported to clear amyloid plaque, an experimental mouse study in the Journal of Alzheimer’s Disease shows that a two-week course of CBD may reduce plaque and improve cognition. Researchers tested aRead
It’s true that not all cannabis products are right for everyone and, therefore cannot be used to treat everyone in the same way. We all have an endocannabinoid system, which is our primary regulatory system and we produce our own endogenous endocannabinoids. When the body has certain deficiencies in endogenousRead
A buyer-beware study, from Massachusetts General Hospital (MGH), shows that medical cannabis products may be poorly labeled and do not always represent accurate levels of actual THC or CBD content. The JAMA Network Open study points out that this can be particularly important when the psychoactive metabolite Δ9-tetrahydrocannabinol (THC), theRead
Not only might cannabis users need more anesthesia during surgery than non-users, they may have increased pain afterwards and use higher doses of opioids while in the hospital, suggests first-of-its kind research being presented at the ANESTHESIOLOGY® 2020 annual meeting. Adding to the growing body of research that shows patientsRead
Inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis are caused by unrestrained inflammation of the gastrointestinal tract. Patients with IBD are at a higher risk of developing colorectal cancer. In a recent study published in iScience by authors from the University of South Carolina, it was shownRead
A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain. No increase in serious adverse events suggested the safety of using cannabinoids to treat acute pain, according to the study published in CannabisRead
A new study shows that cannabis may be helpful to address the effects of post-traumatic stress disorder (PTSD). According to health survey data collected by Statistics Canada from more than 24,000 Canadians, researchers from the BC Centre on Substance Use (BCCSU) and University of British Columbia (UBC) found that peopleRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
